Clinical Trial

Travoprost Intraocular Implant + iStent Infinite

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Protocol Amendment History 3 changes
critical Phase changed: Phase 3 -> Phase 4 2026-06-03
notable Enrollment reduced: 230 -> 150 participants 2026-06-03
minor Trial arms changed: 3 -> 2 2026-06-03
Trial Details
NCT Number NCT06066645
Lead Sponsor Glaukos Corporation
Conditions Glaucoma, Open-Angle
Enrollment 150 participants
Start Date 2023-09-14
Primary Completion 2027-05 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-02